万润新能(688275) - 2025 Q1 - 季度财报

Revenue and Profitability - The company's revenue for Q1 2025 reached ¥2,278,166,335.81, representing a 97.30% increase compared to ¥1,154,685,836.57 in the same period last year[3] - The net profit attributable to shareholders was -¥155,847,073.58, a decline from -¥130,059,834.70 year-on-year[3] - The net loss for Q1 2025 was ¥161,740,719.96, worsening from a net loss of ¥142,557,872.36 in Q1 2024[18] - The gross profit margin for Q1 2025 was approximately -7.5%, down from a margin of -13.0% in Q1 2024[18] Cash Flow and Financial Position - The net cash flow from operating activities was -¥465,468,176.92, a significant decrease of 171.77% compared to ¥648,537,906.95 in the previous year[3] - Net cash flow from operating activities in Q1 2025 was negative at approximately -$465.47 million, compared to a positive cash flow of $648.54 million in Q1 2024[22] - The company's cash and cash equivalents increased to ¥3,650,084,028.43 from ¥2,918,703,772.52, reflecting a growth of approximately 25.1%[13] - The company's cash and cash equivalents at the end of Q1 2025 stood at approximately $818.87 million, down from $2.12 billion at the end of Q1 2024[23] Assets and Liabilities - Total assets increased by 6.42% to ¥18,810,595,808.23 from ¥17,676,221,687.15 at the end of the previous year[4] - The total liabilities increased to ¥13,386,282,012.35 in 2025 from ¥12,088,654,080.57 in 2024, marking an increase of approximately 10.7%[15] - The equity attributable to shareholders decreased to ¥5,460,148,557.22 in 2025 from ¥5,617,508,721.54 in 2024, a decline of approximately 2.8%[15] Research and Development - Research and development expenses totaled ¥65,143,066.00, accounting for 2.86% of revenue, down from 6.52% in the previous year[3] - Research and development expenses for Q1 2025 totaled ¥65,143,066.00, a decrease from ¥75,293,136.51 in Q1 2024, reflecting a reduction of about 13.5%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period was 11,859[8] - The largest shareholder, Liu Shiqi, holds 29,475,240 shares, representing 23.37% of the total shares[8] - The top 10 shareholders hold a combined total of 61.56% of the company's shares[9] Inventory and Receivables - The sales volume of lithium iron phosphate increased by 138% compared to the same period last year, driving revenue growth[6] - The company experienced an increase in accounts receivable, leading to a significant rise in bank acceptance bills issued for raw material purchases[6] - The company's inventory increased to ¥1,324,904,449.64 from ¥943,677,657.71, marking a rise of approximately 40.4%[13] - The accounts receivable balance was reported at ¥2,201,910,889.58, compared to ¥2,043,167,258.18 in the previous period[13] Government Support - The company received government subsidies amounting to ¥9,195,848.86, which positively impacted its financial results[5] Share Buyback Program - The company plans to implement a share buyback program with a minimum investment of ¥8.6067 million and a maximum of ¥17.2133 million[10] - The company has not yet executed the share buyback plan through the Shanghai Stock Exchange as of the reporting date[11] - The company will continue to disclose updates regarding the share buyback plan as progress is made[11] Operating Costs - Total operating costs for Q1 2025 were ¥2,449,246,162.15, compared to ¥1,382,200,250.38 in Q1 2024, indicating an increase of about 77.4%[18]